Investors

Corporate Presentation

The latest Curasight investor presentation.

Curasight A/S
Corporate presentation 2026

Corporate Presentation

Corporate presentation 2026

Download the current corporate presentation for an overview of Curasight’s strategy, uPAR science, clinical programs, development milestones and investment case.

Edition
2026
Format
PDF
Request the presentation

Investor information

News & events

Presentations

Investor and scientific presentation materials.

Investors

Investment Case

Why Curasight. Why uPAR. Why now.

Investors

Financial Reports

Financial reporting and company disclosures.

Seeing cancer. Treating cancer.

Investigational product statementTherapeutic product candidates within the uTRACE® and uTREAT® platform are investigational and they have currently not been approved for commercial use by any regulatory authority.

Forward-looking informationCertain information on this website may contain forward-looking statements regarding development plans, clinical milestones, regulatory activities, partnerships and other future events. Such statements involve risks and uncertainties, and actual outcomes may differ materially. Users should refer to Curasight’s latest market announcements and financial reports for current information.

Medical information statementInformation on this website is provided for general corporate and scientific information only and is not intended as medical advice. Patients should consult qualified healthcare professionals regarding diagnosis and treatment decisions.

+45 22 83 01 60 · info@curasight.com
Copyright 2026 © Curasight